Showing results (601-610 of 637) with videos related to

Sort By:
Pageof 64
Journal of Lipid Research|September 27, 2014
PCSK9 inhibition fails to alter hepatic LDLR, circulating cholesterol, and atherosclerosis in the absence of ApoEBrandon Ason, José W A van der Hoorn, Joyce Chan, et al.
The Journal of Clinical Investigation|January 31, 2023
NLRP12 is an innate immune checkpoint for repressing IFN signatures and attenuating lupus nephritis progressionYen-Po Tsao, Fang-Yu Tseng, Chih-Wei Chao, et al.
Journal of the Chinese Medical Association : JCMA|January 27, 2025
Real-world therapeutic strategies and survival outcomes in advanced HER2 -mutant non-small cell lung cancerRuei-Lin Sun, Pei-Ya Liao, Ying-Ting Liao, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 23, 2008
Beyond tumor necrosis factor receptor: TRADD signaling in toll-like receptorsNien-Jung Chen, Iok In Christine Chio, Wen-Jye Lin, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 10, 2024
Cep57 regulates human centrosomes through multivalent interactionsHung-Wei Yeh, Po-Pang Chen, Tzu-Chen Yeh, et al.
Nano Letters|December 27, 2023
Tungsten Nitride (W5N6): An Ultraresilient 2D SemimetalHao-Ting Chin, Deng-Chi Wang, Desman Perdamaian Gulo, et al.
Nanotechnology|December 29, 2020
Magnetotransport in hybrid InSe/monolayer graphene on SiCChih-Yuan Wang, Yun-Wu Lin, Chiashain Chuang, et al.
Acta Cardiologica Sinica|April 29, 2016
The Effect of Intensified Low Density Lipoprotein Cholesterol Reduction on Recurrent Myocardial Infarction and Cardiovascular MortalityWei-Chun Huang, Tzu-Wen Lin, Kuan-Rau Chiou, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 14, 2022
Nuclear expression of AFF2 C-terminus is a sensitive and specific ancillary marker for DEK::AFF2 carcinoma of the sinonasal tractYing-Ju Kuo, James S Lewis, Tra Truong, et al.
International Journal of Cancer|November 29, 2014
Negative modulation of the epigenetic regulator, UHRF1, by thyroid hormone receptors suppresses liver cancer cell growthSheng-Ming Wu, Wan-Li Cheng, Chia-Jung Liao, et al.
Pageof 64